Reduced D 2 /D 3 Receptor Binding and Glucose Metabolism in a Macaque Model of Huntington's Disease.
Alison R WeissDaniele BertoglioWilliam A LiguoreKristin BrandonJohn TemplonJeanne LinkJodi L McBridePublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
F]FDG are PET imaging biomarkers of mHTT-mediated disease progression that can be used as noninvasive outcome measures in future therapeutic studies with this AAV-mediated HD macaque model. © 2022 International Parkinson and Movement Disorder Society.